Duodenal metastasis from hypernephroma: a case report

Authors

Keywords:

CARCINOMA, RENAL CELL, KIDNEY NEOPLASMS, EPIDEMIOLOGY, NEOPLASM METASTASIS, DUODENUM.

Abstract

Introduction: hypernephroma represents 2 % to 3 % of all adult malignant neoplasms. Its metastatic patterns have not been precisely defined. Duodenal metastasis is considered rare when it occurs.

Case Report: a 48-year-old-male patient, having a history of right nephrectomy due to hypernephroma, at 7 months after the surgery a spread to the lung and renal fossa was found. One year after nephrectomy he was evaluated for chronic anemia, positive fecal occult blood and gastrointestinal symptoms. An opaque colon enema was performed which revealed infiltration of the wall and during gastroscopy a sample of tumor lesion in the duodenum was taken. The pathological analysis of the duodenal biopsy showed an anaplastic large cell tumor lesion with vacuolated cytoplasm, PAS positive and PAS Diastase negative, compatible with metastasis of renal cell carcinoma.

Conclusions: the late appearance of metastases and spontaneous regression of hypernephroma require a comprehensive and prolonged follow-up by the medical staff in charge, in those where the suspicion of dissemination should always prevail during the clinical approach, even when the clinical picture does not suggest the most common sites.

Downloads

Download data is not yet available.

References

1. González García FJ, Hontoria Briso-Montiano JM, Sánchez Chapado M. Tumores malignos del parénquima renal. En Libro del Residente de Urología. 1ra ed. España: Grupo ENE Publicidad; 2007 p. 435-49.

2. Bacaret W, Cabrera M, Ramos G, Varela R, Donoso W. Metástasis inusuales en carcinoma de células renales. Colombian Urology Journal. [Internet] 2019 [citado 31/05/2021]; 28(1): 19-24. Disponible en https://dialnet.unirioja.es/servlet/articulo?codigo=6933728

3. Álvarez-Sánchez IM, Polo-Rosales Y, Zaragoza-Durañona R, Sánchez-Lorenzo IM. Características clínicas y epidemiológicas de pacientes con adenocarcinoma de células renales tratados con nefrectomía radical. Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta. [Internet] 2020 [citado 31/05/2021]; 45(6): 1-6. Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/2335.

4. Alcaraz Asensio A. Tumores del riñón y del urotelio. En Farreras Valentí P, Rozman C. Medicina Interna 18ed. España: Elsevier; 2016

5. Merino C, Molés JR, Rodrigo A, Ferrando J, García J, Primo J et al. Causa poco habitual de hemorragia digestiva alta: metástasis duodenal de adenocarcinoma renal. Gastroenterol Hepatol [Internet] 2005 [citado 20/01/2021]; 28(4): 221-4. Disponible en: https://www.elsevier.es/es-revista-gastroenterologia-hepatologia-14-articulo-causa-poco-habitual-hemorragia-digestiva-13073090

6. Rosas Marcos E, Frisancho Velarde O, Yàbar A. Neoplasia maligna duodenal: perfil clínico-patológico. Rev Gastroenterol Perú [Internet] 2003 [citado 20/01/2021]; 23(2): 99-106 Disponible en: http://www.scielo.org.pe/scielo.php?pid=S1022-51292003000200003&script=sci_abstract

7. Sánchez-Biosca A, Ramos-Lázaro J, Niño-Aragón E, Blancafort-Planas J. Metástasis tardías de carcinoma renal de células claras. Rev Esp Casos Clin Med Intern (RECCMI). [Internet] 2017 [citado 20/01/2021]; 2(2): 102-104. Disponible en: https://reccmi.redaccioncto.com/mod/page/view.php?id=345

8. de León-Castorena E, Ramírez-Vallejo SD. Manifestación atípica de carcinoma renal de células claras. Reporte de un caso. Rev Mex Urol. [Internet] 2018 mayo-junio [citado 31/05/2021]; 78(3):220-224. Disponible en: http://www.scielo.org.mx/scielo.php?pid=S2007-40852018000300220&script=sci_arttext&tlng=es

9. López-Fontana G, Guglielmi JM, López-Fontana R, Valdemoros P, López Laur JD. Carcinoma de células renales metastásico al peritoneo: Una presentación infrecuente. Rev. Arg. de Urol. [Internet] 2020 [citado 31/05/2021]; 85(1): 41-44. Disponible en: https://www.revistasau.org/index.php/revista/article/viewFile/4268/3597

10. Martínez J, Viana E, González M, Lobatón JF, Mora E. Carcinoma de células renales, metastásico a mama y tiroides. Reporte de un caso. Rev. Col. Hematol. Oncol. [Internet] 2018 [citado 31/05/2021]; 5(2):28. Disponible en: https://revista.acho.info/index.php/acho/article/view/48

11. González-Reynaga H, Rodríguez-Komukai E, Bárcena-Ugalde JC. Metástasis ósea como manifestación inicial de carcinoma de células renales. Reporte de un caso. Rev Mex Urol. [Internet] 2018 sept-oct [citado 20/01/2021]; 78(5): 397-401. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S2007-40852018000500397&lng=es&nrm=iso&tlng=es

12. Chaljub Bravo E, et al. Rara coincidencia de dos tumores: mixoma cardíaco e hipernefroma. Presentación de un paciente. CorSalud [Internet] 2018 Oct-Dic [citado 31/05/2021]; 10(4): 330-335. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2078-71702018000400330

13. Villamil Cajoto I, Martínez Lamas C, Balea Vázquez L, Fernández Castro N. Neoplasia primaria múltiple. Estudio de casos en cuidados paliativos. Med Paliat. [Internet] 2019 [citado 31/05/2021]; 26(3):250-253. Disponible en: https://www.medicinapaliativa.es/neoplasia-primaria-multiple-estudio-de-casos-en-cuidados-paliativos441

14. Fonseca Buitrago CL, Sánchez Martínez LM, Pompilio Daza F, Ruiz CA, Cárdenas AM, Vega J, Cabrera M, Arenas NJ. Tumores primarios múltiples sincrónicos: carcinoma de células renales y colorrectal. Urol Colomb [Internet] 2017 [citado: 3/06/2021]; 26(3): 159-163. Disponible en: http://www.redalyc.org/articulo.oa?id=149153548003

Downloads

Published

2021-09-23

How to Cite

1.
Caveda Carrasco R, Ramos-Cordero AE. Duodenal metastasis from hypernephroma: a case report. Rev Ciencias Médicas [Internet]. 2021 Sep. 23 [cited 2025 Sep. 12];25(5):e5151. Available from: https://revcmpinar.sld.cu/index.php/publicaciones/article/view/5151

Issue

Vol. 25 No. 5 (2021)

Section

CASE REPORTS

License

Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.

Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/